Research & Development
12 January 2026 - Taiwanese biotechnology company Formosa Pharmaceuticals, Inc. (TWSE: 6838) announced on Monday that it has entered an exclusive licensing agreement with South Korea-based pharmaceuti...
12 January 2026 - Biopharmaceutical oncology company Summit Therapeutics Inc (NASDAQ:SMMT) announced on Monday that it has submitted a Biologics License Application to the US Food and Drug Administrat...
12 January 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced on Monday that the European Commission has approved Teizeild (teplizumab) to delay the onset of stag...
12 January 2026 - Precision medicine diagnostics company Renalytix plc (LSE: RENX) (OTCQB: RNLXY) announced on Monday that it completed three additional clinical integrations of kidneyintelX.dkd in th...
12 January 2026 - EQT Life Sciences, a part of Swedish private equity company EQT AB (STO: EQT), announced on Monday that it has exited Vivasure Medical Limited, an Ireland-based developer of percutan...
9 January 2026 - Swedish biopharmaceutical company Camurus (STO: CAMX), which develops long-acting medicines for severe and chronic diseases, said on Friday that the US Food and Drug Administration (F...